Cytokines and cancer immunotherapy.
Wolf
S F
SF
Genetics Institute, Andover, MA 01810, USA.
Lee
K
K
Swiniarski
H
H
O'Toole
M
M
Sturmhoefel
K
K
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D000943:Antigens, Differentiation / Q000378:metabolism; D051940:B7-2 Antigen; D018106:CD28 Antigens / Q000378:metabolism; D060908:CTLA-4 Antigen; D016207:Cytokines / Q000627:therapeutic use*; D006801:Humans; D018796:Immunoconjugates; D007167:Immunotherapy / Q000379:methods*; D018664:Interleukin-12 / Q000627:therapeutic use; D008562:Membrane Glycoproteins / Q000378:metabolism; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
D015703:Antigens, CD; D000943:Antigens, Differentiation; D051940:B7-2 Antigen; D018106:CD28 Antigens; C497964:CD86 protein, human; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; C497965:Cd86 protein, mouse; C556707:Ctla4 protein, mouse; D016207:Cytokines; D018796:Immunoconjugates; D008562:Membrane Glycoproteins; D018664:Interleukin-12; D000069594:Abatacept